Pfizer
PFE
$26.25
Share price
-0.04%
Change (1 day)
-34.23%
Change (1 year)
Categories
Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.
Pfizer (PFE) - Cash on Hand
Cash on Hand as of December 2023 : $12.69 B
According to Pfizer's latest financial reports the company has $12.69 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Pfizer - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $12.69 B | -44.18% |
| 2022-12-31 | $22.73 B | -26.83% |
| 2021-12-31 | $31.06 B | 154.18% |
| 2020-12-31 | $12.22 B | 26.72% |
| 2019-12-31 | $9.64 B | -48.78% |
| 2018-12-31 | $18.83 B | -5.8% |
| 2017-12-31 | $19.99 B | 12% |
| 2016-12-31 | $17.85 B | -23.36% |
| 2015-12-31 | $23.29 B | -35.52% |
| 2014-12-31 | $36.12 B | 11.46% |
| 2013-12-31 | $32.40 B | 0.03% |
| 2012-12-31 | $32.39 B | 22.48% |
| 2011-12-31 | $26.45 B | -5.57% |
| 2010-12-31 | $28.01 B | 7.87% |
| 2009-12-31 | $25.96 B | 9.43% |
| 2008-12-31 | $23.73 B | -6.85% |
| 2007-12-31 | $25.47 B | -8.08% |
| 2006-12-31 | $27.71 B | 24.69% |
| 2005-12-31 | $22.22 B | 11.73% |
| 2004-12-31 | $19.89 B | 66.44% |
| 2003-12-31 | $11.95 B | -4.77% |
| 2002-12-31 | $12.55 B | 45.69% |
| 2001-12-31 | $8.61 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 80.67% | 🇺🇸 USA |
 Novartis NVS | $13.96 B | 10.02% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $7.27 B | -42.64% | 🇺🇸 USA |
 Eli Lilly LLY | $2.92 B | -76.93% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | -13.76% | 🇺🇸 USA |
 Merck MRK | $7.09 B | -44.11% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $12.28 B | -3.23% | 🇺🇸 USA |
 AstraZeneca AZN | $5.86 B | -53.82% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $6.35 B | -49.92% | 🇬🇧 UK |